Faiq Firdous
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Faiq Firdous has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Carmen Lenti
Department of Precision Medicine, Universita degli Studi della Campania, 80138, Italy
1 shared publicationFabiana Monfrecola
Department of Precision Medicine, Universita degli Studi della Campania, 80138, Italy
1 shared publication- Faryal Shams
Faculty of Natural Sciences, Islamia College University Peshawar, 25120, Pakistan
1 shared publication - Immad Khan
Institute of Chemical Sciences, University of Peshawar, 25120, Pakistan
1 shared publication - Muhammad Ibrahim
Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
1 shared publication Shana Perrella
Department of Precision Medicine, Universita degli Studi della Campania, 80138, Italy
1 shared publication
Latest Publications
- Open Access
- 13 May 2026
- Published by Science Research Publishers in Journal of Chemistry and Environment
- p. 23-36
Natural Polyphenols Oleuropein and Hydroxytyrosol in Therapeutics: Potentials Against Cancer, Inflammation, Oxidative Stress, and Diabetes
Oleuropein and hydroxytyrosol, two major polyphenolic compounds extracted from the olive tree (Olea europaea), have attracted significant scientific interest due to their strong pharmacological properties, including anticancer, antioxidant, anti-inflammatory, and antidiabetic effects. These compounds play a crucial role in modulating oxidative stress, neutralizing free radicals, and protecting against cellular damage, thereby contributing to neuroprotection, cardiovascular health, and metabolic regulation. Their anticancer potential has been widely demonstrated through their ability to inhibit tumor progression, induce apoptosis, and demonstrate the ability to enhance the efficacy of chemotherapy in various tumor models, including breast and hepatocellular carcinoma. Additionally, their anti-inflammatory activity is attributed to the regulation of cytokines, suppression of NF-κB signaling, and modulation of immune responses, which could be beneficial in managing chronic inflammatory and autoimmune diseases. Moreover, their role in diabetes management has been extensively studied, demonstrating their ability to improve insulin sensitivity and regulate glucose metabolism, and reduce lipid accumulation in hepatic and adipose tissues, thus preventing metabolic complications. Despite extensive preclinical evidence supporting the therapeutic benefits of these compounds, their clinical translation remains challenging due to issues related to bioavailability, stability, and optimal dosage. Future research should focus on improving their pharmacokinetic properties, developing advanced drug delivery systems, and carrying out extensive clinical trials to confirm their safety and effectiveness in humans. The integration of these compounds into functional foods, nutraceuticals, and pharmaceutical formulations holds immense promise for preventive and therapeutic applications, potentially offering natural alternatives to conventional therapeutic agents for managing metabolic, inflammatory, and degenerative diseases.
- 13 May 2026
- Published by Science Research Publishers in Journal of Chemistry and Environment
- p. 23-36
Open AccessNatural Polyphenols Oleuropein and Hydroxytyrosol in Therapeutics: Potentials Against Cancer, Inflammation, Oxidative Stress, and Diabetes
Oleuropein and hydroxytyrosol, two major polyphenolic compounds extracted from the olive tree (Olea europaea), have attracted significant scientific interest due to their strong pharmacological properties, including anticancer, antioxidant, anti-inflammatory, and antidiabetic effects. These compounds play a crucial role in modulating oxidative stress, neutralizing free radicals, and protecting against cellular damage, thereby contributing to neuroprotection, cardiovascular health, and metabolic regulation. Their anticancer potential has been widely demonstrated through their ability to inhibit tumor progression, induce apoptosis, and demonstrate the ability to enhance the efficacy of chemotherapy in various tumor models, including breast and hepatocellular carcinoma. Additionally, their anti-inflammatory activity is attributed to the regulation of cytokines, suppression of NF-κB signaling, and modulation of immune responses, which could be beneficial in managing chronic inflammatory and autoimmune diseases. Moreover, their role in diabetes management has been extensively studied, demonstrating their ability to improve insulin sensitivity and regulate glucose metabolism, and reduce lipid accumulation in hepatic and adipose tissues, thus preventing metabolic complications. Despite extensive preclinical evidence supporting the therapeutic benefits of these compounds, their clinical translation remains challenging due to issues related to bioavailability, stability, and optimal dosage. Future research should focus on improving their pharmacokinetic properties, developing advanced drug delivery systems, and carrying out extensive clinical trials to confirm their safety and effectiveness in humans. The integration of these compounds into functional foods, nutraceuticals, and pharmaceutical formulations holds immense promise for preventive and therapeutic applications, potentially offering natural alternatives to conventional therapeutic agents for managing metabolic, inflammatory, and degenerative diseases.